Alternatives to Bristol Myers Squibb

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Immunotherapy company targeting oncology and autoimmune diseases.

Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer.

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.

A global oncology company developing and commercializing innovative cancer treatments.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A pharmaceutical company focused on developing novel therapies for complex diseases.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company focused on developing treatments for rare metabolic diseases.

A biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company developing next-generation gene writing tools for advanced therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Pillar Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.